Financial Advisors Network’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.04M Buy
6,125
+298
+5% +$132K 0.37% 48
2026
Q1
$2.6M Buy
+5,827
New +$2.72M 0.36% 48
2025
Q1
Sell
-5,518
Closed -$2.22M 215
2024
Q4
$2.22M Buy
+5,518
New +$2.56M 0.37% 51
2019
Q1
Sell
-6,247
Closed -$1.03M 117
2018
Q4
$1.03M Buy
+6,247
New +$1.08M 0.64% 32
2018
Q2
$1.01M Buy
+5,969
New +$925K 0.61% 36

Other funds holding VRTX

Financial Advisors Network's VRTX Position: Q2 2026 in Review

Financial Advisors Network increased its Vertex Pharmaceuticals (VRTX) stake by 5.1% in Q2 2026, buying an estimated $132K and bringing the position to 6,125 shares worth $3.04M. The position accounts for 0.37% of the portfolio, ranked #48.

Financial Advisors Network first reported a position in VRTX in Q2 2018 and has held it in 5 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Financial Advisors Network held 6,125 shares of Vertex Pharmaceuticals worth $3.04M as of Q2 2026.
  • Financial Advisors Network bought 298 Vertex Pharmaceuticals shares in Q2 2026, an estimated $132K.
  • Vertex Pharmaceuticals made up 0.37% of Financial Advisors Network's portfolio in Q2 2026, its #48 holding.
  • Financial Advisors Network first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Financial Advisors Network's 13F filing for Q2 2026, filed 14 Aug 2026.